1. Introduction
Anaplasma phagocytophilum is a Gram-negative, tick-borne, obligate intracellular bacterium that is transmitted by hard-bodied ticks of the Ixodes species and is found worldwide, particularly in the northern hemisphere, as it follows the distribution of its vector [1]. In the US, Europe, and Asia, this pathogen causes an emerging and potentially fatal disease in humans known as human granulocytic anaplasmosis (HGA). In the US, case reports of this disease have increased steadily, from 273 cases in 2000 to 5651 in 2022 (
Despite the organism having a reduced genome, A. phagocytophilum has increased genetic diversity, characterized by the presence of several strains or variants displaying different host predilections, and not all strains infect all hosts [10,11]. Animals that recover from acute disease will become persistent carriers of this bacterium. This characteristic is thought to be enabled in part by the sequential expression of variable surface antigens encoded by the msp2/p44 multigene family [12]. As in many systems of antigenic variation, the antibody to msp2/p44 neutralizes the infection caused by the homologous serotype. However, structurally different MSP2/P44 proteins are created and dominate in different organism peaks during infection; these are only recognized by antibodies generated subsequent to their appearance [13,14,15,16]. The demonstrated basis for antigenic variation is the insertion of a central variable region (CVR) into an msp2/p44 genomic expression site by gene conversion, utilizing the RecF recombination pathway [17,18,19,20]. Different CVRs are present in numerous copies in the A. phagocytophilum genome, flanked by conserved 5′ and 3′ sequences. Genome sequencing of the HZ strain identified 113 copies of msp2/p44, some of which did not contain either or both of the 5′ and 3′ conserved regions [21]. In Anaplasma marginale, which has a similar system for the variation of msp2, there are only seven or eight copies of the msp2 CVR (termed “functional pseudogenes”) available for insertion into the single expression site [22,23]. In that species, additional variation is achieved by the use of different short regions from the CVRs to form complex mosaics, particularly in long-term persistent infections [24,25]. In serial infections with A. phagocytophilum in a mouse model, among 263 expressed pseudogenes, only three mosaics were detected and these involved contributions from only two different pseudogenes in each case [26]. This agrees with previous data suggesting that the primary mechanism of gene conversion is the insertion of a complete CVR into the expression site [27]. This was confirmed using cloned A. phagocytophilum to infect horses and SCID mice that showed recombination break points only in the conserved 5′ and 3′ regions of msp2/p44 copies, suggesting that the msp2/p44 antigenic repertoire is limited [18]. This has led to the idea that long-term infections with A. phagocytophilum could be self-limiting, due to the exhaustion of the msp2/p44 repertoire, unless there is an accompanying variation in the repertoire itself [26,27]. The availability of 28 genome-sequenced strains of A. phagocytophilum from different geographic locations [11] presents an opportunity to examine this possibility at the population level. Specifically, is there evidence for recombination among members of the msp2/p44 repertoire leading to the generation of diversity in the repertoires themselves? We provide here evidence of such recombination that may help to explain the superinfections and persistence of this microorganism and perhaps its adaptation to novel hosts.
2. Materials and Methods
2.1. Selection of A. phagocytophilum Strains for Analysis
To assess for recombination, we employed the strategy of analyzing for evidence of recombination among the silent msp2/p44 repertoires of six highly divergent strains of A. phagocytophilum. We chose to use sequences derived from A. phagocytophilum strains infecting different geographically separated mammalian hosts. Our premise was that strains from such divergent, isolated sources would be unlikely to demonstrate evidence of inter-strain recombination due to the isolation of the host and tick populations, but would still allow the detection of intrastrain recombination if it occurred. This also allowed us to ask whether inter-strain recombination, if detected, occurred only between strains infecting the same mammalian host. Previously, the individual msp2/p44 genes comprising the repertoires of 28 genome-sequenced strains of A. phagocytophilum were characterized (provided in Supplementary Table S2 of Ref. [11]). Those genes sharing at least 99% identity at the nucleotide level were identified and discarded from further analysis, enabling comparisons of the overall variability in the non-identical members of the repertoires. Some strains had nearly identical repertoires, whereas other strain repertoires were completely different, and these differences were based partly on the geographic origin of each strain. For example, two strains isolated from humans in New York state shared most of their repertoires, whereas these two strains shared only ~50% of their repertoires with human-derived strains from the Midwest USA, and a horse-derived strain from Minnesota shared only ~1% of its repertoire with one from California. In the present study, the msp2/p44 repertoires (Supplementary Table S1) of two diverse human strains from New York (HZ2_NY) and Wisconsin (ApWebster_WI), two horse strains from Minnesota (Horse1_MN) and California (Horse1_CA), and two sheep strains from distinct regions of Norway (NorShV1 and ApSheep_NorV2) were selected for analysis.
2.2. Determination of msp2/p44 Repertoires
The repertoires of the msp2/p44 genes in each genome-sequenced strain were determined as described [11]. Briefly, we used an 11-nucleotide sequence present in the 5′ conserved sequence of msp2/p44 to extract all instances of this sequence plus the downstream 469 nucleotides from all A. phagocytophilum genomes. A filter was then applied to verify that each gene encoded at least one of the following known protein characteristics: N-terminal KELAY and N- or C-terminal LAKT amino acid motifs. The 113 msp2/p44 gene loci previously described in the HZ strain [21] include genes characterized as either full-length, silent/reserved, truncated, or fragments. The above methods detected 83 msp2/p44 genes in our re-sequenced HZ2 strain (accession #CP006616; designated HZ2_NY herein) and could not detect partial genes with no 5′ or 3′ conserved region, thought to be necessary for recombination into the MSP2 expression site. These selection criteria were similarly applied to msp2/p44 genes from the human-derived Web_WI strain (accession #LANS00000000; designated ApWebster_WI) (a total of 166 genes); two horse-derived derived strains, Horse1_CA (accession #FLMF00000000) and Horse1_MN (accession #FLMC00000000) (166 genes); and two Norwegian sheep-derived strains, NorShV1 (accession #CP046639) and ApSheep_Norv2 (accession #CP015376) (172 genes). In total, 504 msp2/p44 gene sequences were available for analysis. All sequences are provided in Supplementary Table S1.
2.3. Detection of Recombination
Sequences were aligned with the CLC Bio proprietary multiple sequence alignment module (break cost = 10, cost to extend = 1) for ease of alignment editing. Alignments were manually optimized prior to use in the analysis of recombination. Recombination detection was performed on the alignments using RDP5 v. 5.64 software [28]. For consistency with the demonstrated mechanism of gene conversion [17,18,19,20], the GENECONV module implemented within RDP5 was employed for the analytical screening of all samples, providing multiple comparisons of the linear sequences with Bonferroni correction and a highest acceptable p-value of 0.05. Individual samples were further analyzed with the integrated modules RDP [29], Bootscan [30], Maxchi [31], Chimaera [32], SiSscan [33], PhylPro [34], LARD [35], and 3Seq [36] for the identification of recombination events and/or breakpoint sites, as implemented within RDP5. Modules were adjusted for sensitivity at observed nucleotide change rates. The output of all detected recombinants and the statistical support for them is provided in an Excel-compatible file in Supplementary Table S2. The breakpoint density plots utilized a sequence window size of 100 nucleotides and 1000 permutations to infer the existence of statistically supported recombination hot- and coldspots. These are presented herein as breakpoint p-density plots of probabilities, in which 99% (dark grey) and 95% (light grey) confidence intervals are also shown as shaded areas. Hotspots for recombination are inferred where the black plot lines emerge above the shaded areas, and corresponding areas of low recombination (coldspots) are suggested by plot lines dropping below the shaded areas.
2.4. Polypeptide Structural Comparisons
The msp2/p44 repertoire sequences were translated into predicted MSP2 polypeptides in reading frame 1. Sequences were submitted to the Robetta server (
3. Results
The alignment of the gene repertoires from human-, horse-, or sheep-derived strains of A. phagocytophilum identified similar conserved and variable regions in each case (Supplementary Figure S1), suggesting that the overall structures of the genes comprising these repertoires were consistent and maintained across strains. The conserved and variable regions also conformed to what has been observed previously in different expressed msp2/p44 cDNAs found in human patients experiencing infection with A. phagocytophilum [20]. Indeed, in the alignments of the msp2/p44 genes of all strains, the conservation of the structure and flanking sequences is clear (Supplementary Figure S2). The longest conserved regions were in the 5′ and 3′ flanking regions of genes that have been identified previously as the preferred sites for recombination into the msp2/p44 expression site as part of antigenic variation [18]. Comparing the repertoires of the two human-derived strains from either New York state or Wisconsin, which shared 54% of their repertoires, confirmed the 5′ flanking region as a hotspot for recombination (Figure 1A). Although the 3′ flanking region was not an obvious recombination hotspot in this analysis, examples of recombination were observed there (e.g., Figure 1A, HZ2_NY2014 alignment). Moreover, in an analysis of all msp2/p44 genes included in this study (Supplementary Figures S1 and S2), very strong statistical support for the 3′ recombination hotspot was obtained (Figure 2). The recombination detected was both between individual genes present in the same repertoire and between genes present in either the New York or Wisconsin strains. Interestingly, the same gene in the HZ2_NY repertoire (1399) appeared to have contributed segments to at least two different copies (2026 and 2059) in the Web_WI repertoire. Putative recombinants also extended beyond the 3′ conserved flanking region into the 3′ variable region (e.g., recombinant HZ2_NY1391; Supplementary Table S2). A similar result was obtained when comparing the msp2/p44 gene repertoires found in the two horse-derived strains of A. phagocytophilum from either Minnesota or California, although, in this case, the clear presence of a 3′ recombination hotspot was strongly supported statistically (Figure 1B). In the two sheep-derived strains from different regions of Norway, the putative recombination events appeared to be more complex and extended further into 3′ variable regions of the repertoires. Similar to the human isolates, the 3′ recombination hotspot was not obvious, perhaps because of the resolution of recombination intermediates over a longer region (Figure 1C). In all strains, the sequences showed evidence of prior recombination with unknown msp2/p44 gene forms that were not recovered among the specific genomes sequenced, providing evidence of additional undefined diversity among the A. phagocytophilum strains circulating in the environment. Significantly, it was possible to detect high-probability recombination events between all human, horse, and sheep strains, in all combinations (Supplementary Table S2). Interestingly, high-probability recombination events were detected between Norwegian sheep strain genes and those of the HZ2_NY strain and, in this case, involved the 3′ conserved sequences (Figure 3). The finding of recombination events among geographically broadly distributed strains indicates that there is conservation of variable sequence elements in the silent repertoire during the geographic distribution of this agent, as well as their recombination to broaden diversity. In all scenarios, the 5′ conserved flanking region was observed to be a hotspot for recombination, and a coldspot with a low probability for recombination was maintained immediately 3′ to the 5′ hotspot. The relative inconsistency of the 3′ conserved flanking region as an obvious recombination hotspot is curious and seems to be associated with the host species from which the A. phagocytophilum strains were isolated. This may reflect the greater or lesser importance of sequences in this region of the MSP2 protein for interactions with specific hosts, resulting in differences in the levels of immune selection and the retention of recombinants altered in this region.
4. Discussion
This study demonstrates the outcomes of recombination events occurring between msp2/p44 CVR gene regions that are largely isolate-specific. The circumstances under which these events occurred are unknown. Moreover, it is important to realize that it is not possible from these studies to identify sequences as being parental or recombinant in origin with certainty, as the evolutionary histories of these strains are unknown. From prior genomic analyses [11], however, it is clear that many USA strains infecting humans, dogs, and horses from the Northeast and Midwest are closely related. In these closely related strains, the recombination analysis suggests that the initial recombination events are into the 5′ and 3′ conserved regions (hotspots) flanking the CVR. In the more distantly related strains, the recombination events are more complex and can extend into the 3′ variable region. The reasons for this polarity are not clear but may be related to gene orientations relative to, and the distances from, the origin of replication. In a prior repertoire analysis [39] that required >90% amino acid identity, rather than >99% nucleotide identity as in the current study—a much lower threshold—more repertoire genes were found to be shared. This suggests that point mutations as well as recombination in msp2/p44 cause stepwise evolutionary changes that can lead progressively to entirely different surface antigen repertoires. It is not apparent from these analyses whether the mechanism of recombination among msp2/p44 genes proceeds directly between unexpressed genes in the repertoire, via a multiple step mechanism involving genes present in the expression site specifically, or some measure of both. Gene conversion during antigenic variation normally involves the replacement of transcribed sequences in the expression site with duplicated sequences from the silent repertoire. However, at a much lower frequency, it is likely that this event, which is a form of DNA repair, may proceed in the reverse direction, resulting in the insertion of novel sequence combinations into the silent repertoire.
There are several potential practical implications of the above analyses. First, unlike the gene conversion of the msp2/p44 expression site by different CVRs occurring during a single infection, such repertoire changes are expected to be more permanent and may facilitate the adaptation of the organism to different tick- and animal host species. For example, the structures of the polypeptide sequences encoded by gene copies ApHZ2_NY1445 (minor parent) and ApWebster_WI2017 (recombinant; Figure 1A) are nearly identical, as predicted by Robetta (
Conceptualization, A.F.B.; methodology, A.F.B. and D.R.A.; software, A.F.B. and D.R.A.; validation, A.F.B. and F.L.C.; formal analysis, A.F.B., D.R.A. and F.L.C.; investigation, A.F.B. and D.R.A.; writing—original draft preparation, A.F.B.; writing—review and editing, D.R.A. and F.L.C.; visualization, A.F.B. All authors have read and agreed to the published version of the manuscript.
Not applicable.
Not applicable.
All sequences employed in this project are provided in
The authors thank Joy, Mark, and David Barbet for their essential and unflagging support enabling the conduct of this project.
The authors declare no conflicts of interest.
The following abbreviations are used in this manuscript:
CVR | Central variable region of msp2/p44 genes |
MSP2 | Major surface protein 2 |
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Figure 1. Predicted intra- and inter-strain recombination events between msp2/p44 genes of A. phagocytophilum strains, based upon host. Evidence of recombination is provided for (A) human-derived strains, HZ2_NY and Webster_WI; (B) horse-derived strains, Horse1_CA and Horse1_MN; and (C) sheep-derived strains, NorShV1 and NorShV2. Three examples of areas of recombination between the genes of strains infecting the same host and predicted with a high probability are shown in each case. The top sequence of each alignment was predicted to be the “major parent” (contributing most of the sequence; major parent-specific sequences in blue), the bottom to be the “minor parent” (contributing less; minor parent-specific sequences in pink), and the center sequence is the predicted recombinant gene (sequences attributable to major or minor parents in the corresponding color). Nucleotides that match in the major and minor parents but differ from the recombinant are colored yellow. The positions of the recombination sites used in the analysis are shown above the plot, with the predicted breakpoint sites indicated by inverted triangles above each alignment (yellow triangles indicate sites predicted by GENECONV). Probability values are derived from the GENECONV analysis and indicated beneath the predicted breakpoint site. A breakpoint P-density plot is provided for each analysis, in which the plotted values for the alignment of all human, horse, or sheep isolate-derived sequences correspond to probabilities that recombination breakpoints are not significantly clustered. The central shaded areas indicate the 95% and 99% confidence intervals for the expected degrees of breakpoint clustering in the absence of recombination hot- and coldspots. The fasta sequences used in the alignments are provided in Supplementary Table S1. Statistical results for the full series of recombination and breakpoint analyses performed on all alignments for all combinations are presented in Supplementary Table S2.
Figure 2. Predicted recombination events and their distribution among all msp2/p44 genes of this study. (A) A breakpoint P-density plot of all predicted recombination events. (B) Predicted breakpoint site distribution. All 504 sequences are provided in Supplementary Table S1.
Figure 3. Predicted recombination events between individual HZ2_NY and NorShV1 or NorShV2 msp2/p44 genes. Examples of recombination predicted with high probability between msp2/p44 repertoires of (A) genes of the sheep strain-derived NorShV1 and human isolate-derived HZ2_NY and (B) genes of the sheep strain-derived NorShV2 and HZ2_NY. Breakpoint P-density plots are provided beneath each of the examples for the larger alignments from which each example was extracted. The methods used and the presentation of the results are as described for Figure 1.
Figure 4. Superimposition of predicted structures of a recombinant MSP2 polypeptide and polypeptides encoded by its major and minor parent genes. (A) Structures of polypeptides encoded by genes HZ2_NY1445 (tan) and Webster_WI2017 (blue). (B) Structures of polypeptides encoded by genes HZ2_NY1445 (tan) and Webster_WI2064 (blue). In this example, HZ2_NY1445 is a predicted recombinant gene, Webster_WI2017 is the minor parent, and Webster_WI2064 is the major parent.
Supplementary Materials
The following supporting information can be downloaded at:
References
1. Stuen, S.; Granquist, E.G.; Silaghi, C. Anaplasma phagocytophilum—A widespread multi-host pathogen with highly adaptive strategies. Front. Cell. Infect. Microbiol.; 2013; 3, 31. [DOI: https://dx.doi.org/10.3389/fcimb.2013.00031]
2. Bakken, J.S.; Dumler, J.S.; Chen, S.M.; Eckman, M.R.; Van Etta, L.L.; Walker, D.H. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?. J. Am. Med. Assoc.; 1994; 272, pp. 212-218. [DOI: https://dx.doi.org/10.1001/jama.1994.03520030054028]
3. Dumler, J.S. Human ehrlichiosis: Clinical, laboartory, epidemiologic, and pathologic considerations. Rickettsiae and Rickettsial Diseases; Kazár, J.; Toman, R. Veda: Bratislava, Slovakia, 1996; pp. 287-302.
4. Rivera, J.E.; Young, K.; Kwon, T.S.; McKenzie, P.A.; Grant, M.A.; McBride, D.A. Anaplasmosis presenting with respiratory symptoms and pneumonitis. Open Forum Infect. Dis.; 2020; 7, ofaa265. [DOI: https://dx.doi.org/10.1093/ofid/ofaa265]
5. Dumler, J.S. The biological basis of severe outcomes in Anaplasma phagocytophilum infection. FEMS Immunol. Med. Microbiol.; 2012; 64, pp. 13-20. [DOI: https://dx.doi.org/10.1111/j.1574-695X.2011.00909.x]
6. Li, H.; Zhou, Y.; Wang, W.; Guo, D.; Huang, S.; Jie, S. The clinical characteristics and outcomes of patients with human granulocytic anaplasmosis in China. Int. J. Infect. Dis.; 2011; 15, pp. 859-866. [DOI: https://dx.doi.org/10.1016/j.ijid.2011.09.008]
7. Stuen, S. Anaplasma phagocytophilum—The most widespread tick-borne infection in animals in Europe. Vet. Res. Commun.; 2007; 31, pp. 79-84. [DOI: https://dx.doi.org/10.1007/s11259-007-0071-y]
8. Samaddar, S.; Rolandelli, A.; O’Neal, A.J.; Laukaitis-Yousey, H.J.; Marnin, L.; Singh, N.; Wang, X.; Butler, L.R.; Rangghran, P.; Kitsou, C. et al. Bacterial reprogramming of tick metabolism impacts vector fitness and susceptibility to infection. Nat. Microbiol.; 2024; 9, pp. 2278-2291. [DOI: https://dx.doi.org/10.1038/s41564-024-01756-0]
9. Zhang, D.; Yu, L.; Tang, H.; Niu, H. Anaplasma phagocytophilum AFAP targets the host nucleolus and inhibits induced apoptosis. Front. Microbiol.; 2025; 15, 1533640. [DOI: https://dx.doi.org/10.3389/fmicb.2024.1533640]
10. Rikihisa, Y. Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum. Clin. Microbiol. Rev.; 2011; 24, pp. 469-489. [DOI: https://dx.doi.org/10.1128/CMR.00064-10]
11. Crosby, F.L.; Eskeland, S.; Bø-Granquist, E.G.; Munderloh, U.G.; Price, L.D.; Al-Khedery, B.; Stuen, S.; Barbet, A.F. Comparative whole genome analysis of an Anaplasma phagocytophilum strain isolated from Norwegian sheep. Pathogens; 2022; 11, 601. [DOI: https://dx.doi.org/10.3390/pathogens11050601]
12. Brown, W.C.; Barbet, A.F. Persistent Infections and immunity in ruminants to arthropod-borne bacteria in the family Anaplasmataceae. Annu. Rev. Anim. Biosci.; 2016; 4, pp. 177-197. [DOI: https://dx.doi.org/10.1146/annurev-animal-022513-114206]
13. Wang, X.; Kikuchi, T.; Rikihisa, Y. Two monoclonal antibodies with defined epitopes of P44 major surface proteins neutralize Anaplasma phagocytophilum by distinct mechanisms. Infect. Immun.; 2006; 74, pp. 1873-1882. [DOI: https://dx.doi.org/10.1128/IAI.74.3.1873-1882.2006]
14. Wang, X.; Rikihisa, Y.; Lai, T.H.; Kumagai, Y.; Zhi, N.; Reed, S.M. Rapid sequential changeover of expressed p44 genes during the acute phase of Anaplasma phagocytophilum infection in horses. Infect. Immun.; 2004; 72, pp. 6852-6859. [DOI: https://dx.doi.org/10.1128/IAI.72.12.6852-6859.2004]
15. Granquist, E.G.; Stuen, S.; Crosby, L.; Lundgren, A.M.; Alleman, A.R.; Barbet, A.F. Variant-specific and diminishing immune responses towards the highly variable MSP2(P44) outer membrane protein of Anaplasma phagocytophilum during persistent infection in lambs. Vet. Immunol. Immunopathol.; 2010; 133, pp. 117-124. [DOI: https://dx.doi.org/10.1016/j.vetimm.2009.07.009]
16. Granquist, E.G.; Stuen, S.; Lundgren, A.M.; Bråten, M.; Barbet, A.F. Outer membrane protein sequence variation in lambs experimentally infected with Anaplasma phagocytophilum. Infect. Immun.; 2008; 76, pp. 120-126. [DOI: https://dx.doi.org/10.1128/IAI.01206-07]
17. Barbet, A.F.; Meeus, P.F.; Bélanger, M.; Bowie, M.V.; Yi, J.; Lundgren, A.M.; Alleman, A.R.; Wong, S.J.; Chu, F.K.; Munderloh, U.G. et al. Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum. Infect. Immun.; 2003; 71, pp. 1706-1718. [DOI: https://dx.doi.org/10.1128/IAI.71.4.1706-1718.2003]
18. Lin, Q.; Rikihisa, Y. Establishment of cloned Anaplasma phagocytophilum and analysis of p44 gene conversion within an infected horse and infected SCID mice. Infect. Immun.; 2005; 73, pp. 5106-5114. [DOI: https://dx.doi.org/10.1128/IAI.73.8.5106-5114.2005]
19. Lin, Q.; Zhang, C.; Rikihisa, Y. Analysis of involvement of the RecF pathway in p44 recombination in Anaplasma phagocytophilum and in Escherichia coli by using a plasmid carrying the p44 expression and p44 donor loci. Infect. Immun.; 2006; 74, pp. 2052-2062. [DOI: https://dx.doi.org/10.1128/IAI.74.4.2052-2062.2006]
20. Lin, Q.; Ohashi, N.; Horowitz, H.W.; Aguero-Rosenfeld, M.E.; Raffalli, J.; Wormser, G.P.; Rikihisa, Y. Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J. Clin. Microbiol.; 2002; 40, pp. 2981-2988. [DOI: https://dx.doi.org/10.1128/JCM.40.8.2981-2988.2002]
21. Dunning Hotopp, J.C.; Lin, M.; Madupu, R.; Crabtree, J.; Angiuoli, S.V.; Eisen, J.A.; Seshadri, R.; Ren, Q.; Wu, M.; Utterback, T.R. et al. Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet.; 2006; 2, e21. [DOI: https://dx.doi.org/10.1371/journal.pgen.0020021]
22. Brayton, K.A.; Kappmeyer, L.S.; Herndon, D.R.; Dark, M.J.; Tibbals, D.L.; Palmer, G.H.; McGuire, T.C.; Knowles, D.P. Complete genome sequencing of Anaplasma marginale reveals that the surface is skewed to two superfamilies of outer membrane proteins. Proc. Natl. Acad. Sci. USA; 2005; 102, pp. 844-849. [DOI: https://dx.doi.org/10.1073/pnas.0406656102] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15618402]
23. Palmer, G.H.; Bankhead, T.; Seifert, H.S. Antigenic variation in bacterial pathogens. Microbiol. Spectrum; 2016; 4, vmbf-0005-2015. [DOI: https://dx.doi.org/10.1128/microbiolspec.VMBF-0005-2015] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26999387]
24. Barbet, A.F.; Lundgren, A.M.; Yi, J.; Rurangirwa, F.R.; Palmer, G.H. Antigenic variation of Anaplasma marginale by expression of MSP2 mosaics. Infect. Immun.; 2000; 68, pp. 6133-6138. [DOI: https://dx.doi.org/10.1128/IAI.68.11.6133-6138.2000]
25. Futse, J.E.; Brayton, K.A.; Knowles, D.P.; Palmer, G.H. Structural basis for segmental gene conversion in generation of Anaplasma marginale outer membrane protein variants. Mol. Microbiol.; 2005; 57, pp. 212-221. [DOI: https://dx.doi.org/10.1111/j.1365-2958.2005.04670.x]
26. Rejmanek, D.; Foley, P.; Barbet, A.F.; Foley, J. Evolution of antigen variation in the tick-borne pathogen Anaplasma phagocytophilum. Mol. Biol. Evol.; 2012; 29, pp. 391-400. [DOI: https://dx.doi.org/10.1093/molbev/msr229] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21965342]
27. Lin, Q.; Rikihisa, Y.; Ohashi, N.; Zhi, N. Mechanisms of variable p44 expression by Anaplasma phagocytophilum. Infect. Immun.; 2003; 71, pp. 5650-5661. [DOI: https://dx.doi.org/10.1128/IAI.71.10.5650-5661.2003]
28. Martin, D.P.; Varsani, A.; Roumagnac, P.; Botha, G.; Maslamoney, S.; Schwab, T.; Kelz, Z.; Kumar, V.; Murrell, B. RDP5: A computer program for analyzing recombination in, and removing signals of recombination from, nucleotide sequence datasets. Virus Evol.; 2021; 7, veaa087. [DOI: https://dx.doi.org/10.1093/ve/veaa087]
29. Martin, D.; Rybicki, E. RDP: Detection of recombination amongst aligned sequences. Bioinformatics; 2000; 16, pp. 562-563. [DOI: https://dx.doi.org/10.1093/bioinformatics/16.6.562]
30. Salminen, M.O.; Carr, J.K.; Burke, D.S.; McCutchan, F.E. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by BOOTSCANning. AIDS Res. Hum. Retroviruses; 1995; 11, pp. 1423-1425. [DOI: https://dx.doi.org/10.1089/aid.1995.11.1423] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8573403]
31. Maynard Smith, J. Analyzing the mosaic structure of genes. J. Mol. Evol.; 1992; 34, pp. 126-129.
32. Posada, D.; Crandall, K.A. Evaluation of methods for detecting recombination from DNA sequences: Computer simulations. Proc. Natl. Acad. Sci. USA; 2001; 98, pp. 13757-13762. [DOI: https://dx.doi.org/10.1073/pnas.241370698] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11717435]
33. Gibbs, M.J.; Armstrong, J.S.; Gibbs, A.J. Sister-Scanning: A Monte Carlo procedure for assessing signals in recombinant sequences. Bioinformatics; 2000; 16, pp. 573-582. [DOI: https://dx.doi.org/10.1093/bioinformatics/16.7.573]
34. Weiller, G.F. Phylogenetic profiles: A graphical method for detecting genetic recombinations in homologous sequences. Mol. Biol. Evol.; 1998; 15, pp. 326-335. [DOI: https://dx.doi.org/10.1093/oxfordjournals.molbev.a025929] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9501499]
35. Holmes, E.C.; Worobey, M.; Rambaut, A. Phylogenetic evidence for recombination in Dengue virus. Mol. Biol. Evol.; 1999; 16, 405. [DOI: https://dx.doi.org/10.1093/oxfordjournals.molbev.a026121] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10331266]
36. Lam, H.M.; Ratmann, O.; Boni, M.F. Improved algorithmic complexity for the 3SEQ recombination detection algorithm. Mol. Biol. Evol.; 2018; 35, pp. 247-251. [DOI: https://dx.doi.org/10.1093/molbev/msx263]
37. Kim, D.E.; Chivian, D.; Baker, D. Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res.; 2004; 32, (Suppl. S2), pp. W526-W531. [DOI: https://dx.doi.org/10.1093/nar/gkh468] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15215442]
38. Pettersen, E.F.; Goddard, T.D.; Huang, C.C.; Couch, G.S.; Greenblatt, D.M.; Meng, E.C.; Ferrin, T.E. UCSF Chimera- a visualization system for exploratory research and analysis. J. Comput. Chem.; 2004; 25, pp. 1605-1612. [DOI: https://dx.doi.org/10.1002/jcc.20084]
39. Barbet, A.F.; Al-Khedery, B.; Stuen, S.; Granquist, E.G.; Felsheim, R.F.; Munderloh, U.G. An emerging tick-borne disease of humans is caused by a subset of strains with conserved genome structure. Pathogens; 2013; 2, pp. 544-555. [DOI: https://dx.doi.org/10.3390/pathogens2030544] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25437207]
40. Park, J.; Choi, K.S.; Dumler, J.S. Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes. Infect. Immun.; 2003; 71, pp. 4018-4025. [DOI: https://dx.doi.org/10.1128/IAI.71.7.4018-4025.2003]
41. Castañeda-Ortiz, E.J.; Ueti, M.W.; Camacho-Nuez, M.; Mosqueda, J.J.; Mousel, M.R.; Johnson, W.C.; Palmer, G.H. Association of Anaplasma marginale strain superinfection with infection prevalence within tropical regions. PLoS ONE; 2015; 10, e0120748. [DOI: https://dx.doi.org/10.1371/journal.pone.0120748]
42. Koku, R.; Futse, J.E.; Morrison, J.; Brayton, K.A.; Palmer, G.H.; Noh, S.M. The use of the antigenically variable Major Surface Protein 2 in the establishment of superinfection during natural tick transmission of Anaplasma marginale in Southern Ghana. Infect. Immun.; 2023; 91, e0050122. [DOI: https://dx.doi.org/10.1128/iai.00501-22]
43. Singu, V.; Liu, H.; Cheng, C.; Ganta, R.R. Ehrlichia chaffeensis expresses macrophage- and tick cell-specific 28-kilodalton outer membrane proteins. Infect. Immun.; 2005; 73, pp. 79-87. [DOI: https://dx.doi.org/10.1128/IAI.73.1.79-87.2005]
44. Singu, V.; Peddireddi, L.; Sirigireddy, K.R.; Cheng, C.; Munderloh, U.G.; Ganta, R.R. Unique macrophage and tick cell-specific protein expression from the p28/p30-outer membrane protein multigene locus in Ehrlichia chaffeensis and Ehrlichia canis. Cell. Microbiol.; 2006; 8, pp. 1475-1487. [DOI: https://dx.doi.org/10.1111/j.1462-5822.2006.00727.x]
45. Duan, N.; Ma, X.; Cui, H.; Wang, Z.; Chai, Z.; Yan, J.; Li, X.; Feng, Y.; Cao, Y.; Jin, Y. et al. Insights into the mechanism regulating the differential expression of the P28-OMP outer membrane proteins in obligatory intracellular pathogen. Emerg. Microbes Infec.; 2021; 10, pp. 461-471. [DOI: https://dx.doi.org/10.1080/22221751.2021.1899054]
46. Nyika, A.; Barbet, A.F.; Burridge, M.J.; Mahan, S.M. DNA vaccination with map1 gene followed by protein boost augments protection against challenge with Cowdria ruminantium, the agent of heartwater. Vaccine; 2002; 20, pp. 1215-1225. [DOI: https://dx.doi.org/10.1016/S0264-410X(01)00430-3]
47. Crocquet-Valdes, P.A.; Thirumalapura, N.R.; Ismail, N.; Yu, X.; Saito, T.B.; Stevenson, H.L.; Pietzsch, C.A.; Thomas, S.; Walker, D.H. Immunization with Ehrlichia P28 outer membrane proteins confers protection in a mouse model of ehrlichiosis. Clin. Vaccine Immunol.; 2011; 18, pp. 2018-2025. [DOI: https://dx.doi.org/10.1128/CVI.05292-11]
48. Budachetri, K.; Lin, M.; Chien, R.C.; Zhang, W.; Brock, G.N.; Rikihisa, Y. Efficacy and immune correlates of OMP-1B and VirB2-4 vaccines for protection of dogs from tick transmission of Ehrlichia chaffeensis. mBio; 2022; 13, e0214022. [DOI: https://dx.doi.org/10.1128/mbio.02140-22] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36342170]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Anaplasma phagocytophilum, a tick-borne Rickettsiales, causes an emerging disease among humans and animals called granulocytic anaplasmosis. The organism expresses an immunodominant surface protein, MSP2/P44, that undergoes rapid antigenic variation during single infections due to gene conversion at a single genomic expression site with sequences from one of ~100 transcriptionally silent genes known as “functional pseudogenes”. Most studies have indicated that the predominant gene conversion mechanism is the insertion of complete central variable regions (CVRs) into the msp2/p44 expression site via homologous recombination through 5′ and 3′ conserved regions. This suggests that it is possible that persistent infections by one strain may be self-limiting due to the exhaustion of the antigenic repertoire. However, if there is substantial recombination within the functional pseudogene repertoires themselves, it is likely that these repertoires have a high rate of change. This was investigated here by analyzing the repertoires of msp2/p44 functional pseudogenes in genome-sequenced A. phagocytophilum from widely different geographic locations in the USA and Europe. The data strongly support the probability of recombination events having occurred within and between msp2/p44 repertoires that is not limited to the 5′ and 3′ conserved regions of the CVR, greatly expanding the total potential variation. Continual variation of msp2/p44 repertoires is predicted to aid the organism in overcoming existing immunity in the individual and causing superinfections among immune populations, and this may facilitate the adaptation of the microorganism to infect and cause disease in different species.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Department of Infectious Diseases and Immunology, University of Florida, Gainesville, FL 32611-0880, USA
2 Department of Infectious Diseases and Immunology, University of Florida, Gainesville, FL 32611-0880, USA